Datta Niloy Ranjan, Khan Shaka, Marder Dietmar, Zwahlen Daniel, Bodis Stephan
RadioOnkologieZentrum, KSA-KSB, Kantonsspital Aarau, Tellstrasse, 5001, Aarau, Switzerland.
Department of Radiotherapy, Kantonsspital Graubünden, Chur, Switzerland.
Strahlenther Onkol. 2016 Sep;192(9):599-608. doi: 10.1007/s00066-016-1022-8. Epub 2016 Jul 25.
The purpose of this study was to evaluate the present status of radiotherapy infrastructure and human resources in Switzerland and compute projections for 2020.
The European Society of Therapeutic Radiation Oncology "Quantification of Radiation Therapy Infrastructure and Staffing" guidelines (ESTRO-QUARTS) and those of the International Atomic Energy Agency (IAEA) were applied to estimate the requirements for teleradiotherapy (TRT) units, radiation oncologists (RO), medical physicists (MP) and radiotherapy technologists (RTT). The databases used for computation of the present gap and additional requirements are (a) Global Cancer Incidence, Mortality and Prevalence (GLOBOCAN) for cancer incidence (b) the Directory of Radiotherapy Centres (DIRAC) of the IAEA for existing TRT units (c) human resources from the recent ESTRO "Health Economics in Radiation Oncology" (HERO) survey and (d) radiotherapy utilization (RTU) rates for each tumour site, published by the Ingham Institute for Applied Medical Research (IIAMR).
In 2015, 30,999 of 45,903 cancer patients would have required radiotherapy. By 2020, this will have increased to 34,041 of 50,427 cancer patients. Switzerland presently has an adequate number of TRTs, but a deficit of 57 ROs, 14 MPs and 36 RTTs. By 2020, an additional 7 TRTs, 72 ROs, 22 MPs and 66 RTTs will be required. In addition, a realistic dynamic model for calculation of staff requirements due to anticipated changes in future radiotherapy practices has been proposed. This model could be tailor-made and individualized for any radiotherapy centre.
A 9.8 % increase in radiotherapy requirements is expected for cancer patients over the next 5 years. The present study should assist the stakeholders and health planners in designing an appropriate strategy for meeting future radiotherapy needs for Switzerland.
本研究旨在评估瑞士放射治疗基础设施和人力资源的现状，并计算2020年的预测数据。
应用欧洲放射治疗与肿瘤学学会“放射治疗基础设施与人员配备量化”指南（ESTRO - QUARTS）以及国际原子能机构（IAEA）的指南，来估算远程放射治疗（TRT）单元、放射肿瘤学家（RO）、医学物理学家（MP）和放射治疗技师（RTT）的需求。用于计算当前差距和额外需求的数据库包括：（a）全球癌症发病率、死亡率和患病率（GLOBOCAN）用于癌症发病率；（b）国际原子能机构的放射治疗中心目录（DIRAC）用于现有TRT单元；（c）近期欧洲放射治疗与肿瘤学学会“放射肿瘤学卫生经济学”（HERO）调查中的人力资源数据；（d）英厄姆应用医学研究所（IIAMR）公布的各肿瘤部位的放射治疗利用率（RTU）。
2015年，45903名癌症患者中有30999名需要放射治疗。到2020年，这一数字将增至50427名癌症患者中的34041名。瑞士目前TRT单元数量充足，但RO短缺57名，MP短缺14名，RTT短缺36名。到2020年，还将需要额外的7个TRT单元、72名RO、22名MP和66名RTT。此外，还提出了一个用于计算因未来放射治疗实践预期变化而产生的人员需求的现实动态模型。该模型可为任何放射治疗中心量身定制并个性化。
预计未来5年癌症患者的放射治疗需求将增长9.8%。本研究应有助于利益相关者和卫生规划者制定适当战略，以满足瑞士未来的放射治疗需求。
